Fluoroalkyl groups profoundly affect the physical properties of pharmaceuticals and influence almost all metrics associated with their pharmacokinetic and pharmacodynamic profile1,2,3,4. Drug candidates increasingly contain trifluoromethyl (CF3) and difluoromethyl (CF2H) groups, and the same trend in agrochemical development shows that the effect of fluoroalkylation translates across human, insect and plant life5,6. New fluoroalkylation reactions have undoubtedly stimulated this shift; however, methods that directly convert C–H bonds into C–CF2X groups (where X is F or H) in complex drug-like molecules are rare7,8,9,10,11,12,13. Pyridines are the most common aromatic heterocycles in pharmaceuticals14, but only one approach—via fluoroalkyl radicals—is viable for achieving pyridyl C–H fluoroalkylation in the elaborate structures encountered during drug development15,16,17. Here we develop a set of bench-stable fluoroalkylphosphines that directly convert the C–H bonds in pyridine building blocks, drug-like fragments and pharmaceuticals into fluoroalkyl derivatives. No preinstalled functional groups or directing groups are required. The reaction tolerates a variety of sterically and electronically distinct pyridines, and is exclusively selective for the 4-position in most cases. The reaction proceeds through initial formation of phosphonium salts followed by sp2–sp3 coupling of phosphorus ligands—an underdeveloped manifold for forming C–C bonds.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Müller, K., Faeh, C. & Diederich, F. Fluorine in pharmaceuticals: looking beyond intuition. Science 317, 1881–1886 (2007).
Hagmann, W. K. The many roles for fluorine in medicinal chemistry. J. Med. Chem. 51, 4359–4369 (2008).
Zhou, Y. et al. Next generation of fluorine-containing pharmaceuticals, compounds currently in phase II–III clinical trials of major pharmaceutical companies: new structural trends and therapeutic areas. Chem. Rev. 116, 422–518 (2016).
Zafrani, Y. et al. Difluoromethyl bioisostere: examining the “lipophilic hydrogen bond donor” concept. J. Med. Chem. 60, 797–804 (2017).
Jeschke, P. The unique role of fluorine in the design of active ingredients for modern crop protection. ChemBioChem 5, 570–589 (2004).
Burriss, A. et al. The importance of trifluoromethyl pyridines in crop protection. Pest Manag. Sci. 74, 1228–1238 (2018).
Alonso, C., Martínez de Marigorta, E., Rubiales, G. & Palacios, F. Carbon trifluoromethylation reactions of hydrocarbon derivatives and heteroarenes. Chem. Rev. 115, 1847–1935 (2015).
Barata-Vallejo, S., Lantaño, B. & Postigo, A. Recent advances in trifluoromethylation reactions with electrophilic trifluoromethylating reagents. Chem. Eur. J. 20, 16806–16829 (2014).
Yerien, D. E., Barata-Vallejo, S. & Postigo, A. Difluoromethylation reactions of organic compounds. Chem. Eur. J. 23, 14676–14701 (2017).
Postigo, A. in Late-Stage Fluorination of Bioactive Molecules and Biologically-Relevant Substrates (ed. Postigo, A.) 243–285 (Elsevier, 2019).
Barata-Vallejo, S. & Postigo, A. Photocatalytic difluoromethylation reactions of aromatic compounds and aliphatic multiple C–C bonds. Molecules 24, 4483 (2019).
Lemos, A., Lemaire, C. & Luxen, A. Progress in difluoroalkylation of organic substrates by visible light photoredox catalysis. Adv. Synth. Catal. 361, 1500–1537 (2019).
Ye, F. et al. Aryl sulfonium salts for site-selective late-stage trifluoromethylation. Angew. Chem. Int. Ed. 58, 14615–14619 (2019).
Vitaku, E., Smith, D. T. & Njardarson, J. T. Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem. 57, 10257–10274 (2014).
Nagib, D. A. & MacMillan, D. W. C. Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis. Nature 480, 224–228 (2011).
Fujiwara, Y. et al. Practical and innate carbon-hydrogen functionalization of heterocycles. Nature 492, 95–99 (2012).
Beatty, J. W., Douglas, J. J., Cole, K. P. & Stephenson, C. R. J. A scalable and operationally simple radical trifluoromethylation. Nat. Commun. 6, 7919 (2015).
Ekroos, M. & Sjögren, T. Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc. Natl Acad. Sci. USA 103, 13682–13687 (2006).
Gibbs, M. A. & Hosea, N. A. Factors affecting the clinical development of cytochrome P450 3A substrates. Clin. Pharmacokinet. 42, 969–984 (2003).
O’Hara, F., Blackmond, D. G. & Baran, P. S. Radical-based regioselective C–H functionalization of electron-deficient heteroarenes: scope, tunability, and predictability. J. Am. Chem. Soc. 135, 12122–12134 (2013).
Nagase, M., Kuninobu, Y. & Kanai, M. 4-Position-selective C–H perfluoroalkylation and perfluoroarylation of six-membered heteroaromatic compounds. J. Am. Chem. Soc. 138, 6103–6106 (2016).
Finet, J.-P. Ligand Coupling Reactions with Heteroatomic Compounds 1st edn (Pergamon, 1998).
Uchida, Y., Onoue, K., Tada, N. & Nagao, F. Ligand coupling reaction on the phosphorus atom. Tetrahedr. Lett. 30, 567–570 (1989).
Hilton, M. C. et al. Heterobiaryl synthesis by contractive C–C coupling via P(V) intermediates. Science 362, 799–804 (2018).
Boyle, B. T., Hilton, M. C. & McNally, A. Nonsymmetrical bis-azine biaryls from chloroazines: a strategy using phosphorus ligand-coupling. J. Am. Chem. Soc. 141, 15441–15449 (2019).
Krishnamurti, V., Barrett, C. & Prakash, G. K. S. Siladifluoromethylation and deoxo-trifluoromethylation of PV–H compounds with TMSCF3: route to PV–CF2– transfer reagents and P–CF3 compounds. Org. Lett. 21, 1526–1529 (2019).
Anders, E. & Markus, F. Neue methode zur regiospezifischen substitution einiger reaktionsträcer N-heteroaromatischer ringsysteme. Tetrahedr. Lett. 28, 2675–2676 (1987).
Hilton, M. C., Dolewski, R. D. & McNally, A. Selective functionalization of pyridines via heterocyclic phosphonium salts. J. Am. Chem. Soc. 138, 13806–13809 (2016).
Fasano, V., LaFortune, J. H. W., Bayne, J. M., Ingleson, M. J. & Stephan, D. W. Air- and water-stable Lewis acids: synthesis and reactivity of P-trifluoromethyl electrophilic phosphonium cations. Chem. Commun. 54, 662–665 (2018).
Barbe, G. & Charette, A. B. Highly chemoselective metal-free reduction of tertiary amides. J. Am. Chem. Soc. 130, 18–19 (2008).
Fujimoto, H., Kodama, T., Yamanaka, M. & Tobisu, M. Phosphine-catalyzed intermolecular acylfluorination of alkynes via a P(V) intermediate. J. Am. Chem. Soc. 142, 17323–17328 (2020).
Levy, J. N., Alegre-Requena, J. V., Liu, R., Paton, R. S. & McNally, A. Selective halogenation of pyridines using designed phosphine reagents. J. Am. Chem. Soc. 142, 11295–11305 (2020).
Lim, S. & Radosevich, A. T. Round-trip oxidative addition, ligand metathesis, and reductive elimination in a PIII/PV synthetic cycle. J. Am. Chem. Soc. 142, 16188–16193 (2020).
Dolewski, R. D., Fricke, P. J. & McNally, A. Site-selective switching strategies to functionalize polyazines. J. Am. Chem. Soc. 140, 8020–8026 (2018).
Ji, Y. et al. Innate C–H trifluoromethylation of heterocycles. Proc. Natl Acad. Sci. USA 108, 14411–14415 (2011).
Fujiwara, Y. et al. A new reagent for direct difluoromethylation. J. Am. Chem. Soc. 134, 1494–1497 (2012).
This work was supported by the National Science Foundation (NSF) under grant number 1753087. We acknowledge the Rocky Mountain Advanced Computing Consortium (RMACC) Summit supercomputer, supported by the NSF (grants ACI-1532235 and ACI-1532236), and the Extreme Science and Engineering Discovery Environment (XSEDE) (allocations TG-CHE180056 and TG-CHE200033). We thank M. J. Gaunt for help in preparing the manuscript. We dedicate this paper to the memory of Robert M. Williams.
A patent application based on the subject matter of this manuscript has been filed with the United States Patent and Trademark Office.
Peer review information Nature thanks the anonymous reviewers for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This file contains Supplementary Sections 1-18, including Supplementary Figures 1-18, Supplementary Tables 1-10 and 1H, 13C, 19F, and 31P Spectra data- see Contents page for details.
About this article
Cite this article
Zhang, X., Nottingham, K.G., Patel, C. et al. Phosphorus-mediated sp2–sp3 couplings for C–H fluoroalkylation of azines. Nature 594, 217–222 (2021). https://doi.org/10.1038/s41586-021-03567-3